Literature DB >> 30740425

Benefit of nephron sparing surgery translates into lower cancer specific mortality in patients with localized renal cell carcinoma.

Francesco A Mistretta1,2, Elio Mazzone1,3,4, Sophie Knipper1,5, Pierre I Karakiewicz1,6.   

Abstract

Entities:  

Year:  2018        PMID： 30740425      PMCID： PMC6330610          DOI： 10.21037/atm.2018.11.37

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  12 in total

1.  Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort.

Authors:  Pei-Hsuan Weng; Kuan-Yu Hung; Hsien-Liang Huang; Jen-Hau Chen; Pei-Kun Sung; Kuo-Chin Huang
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Reduced estimated GFR and cancer mortality.

Authors:  Samuel Iff; Jonathan C Craig; Robin Turner; Jeremy R Chapman; Jie J Wang; Paul Mitchell; Germaine Wong
Journal:  Am J Kidney Dis       Date:  2013-08-30       Impact factor: 8.860

3.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

4.  Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.

Authors:  Alessandro Larcher; Umberto Capitanio; Carlo Terrone; Alessandro Volpe; Paolo De Angelis; Federico Dehó; Nicola Fossati; Paolo Dell'Oglio; Alessandro Antonelli; Maria Furlan; Claudio Simeone; Sergio Serni; Marco Carini; Andrea Minervini; Cristian Fiori; Francesco Porpiglia; Alberto Briganti; Francesco Montorsi; Roberto Bertini
Journal:  J Urol       Date:  2016-05-25       Impact factor: 7.450

5.  Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses.

Authors:  Christopher J Weight; Benjamin T Larson; Amr F Fergany; Tianming Gao; Brian R Lane; Steven C Campbell; Jihad H Kaouk; Eric A Klein; Andrew C Novick
Journal:  J Urol       Date:  2010-02-19       Impact factor: 7.450

6.  A non-cancer-related survival benefit is associated with partial nephrectomy.

Authors:  Maxine Sun; Quoc-Dien Trinh; Marco Bianchi; Jens Hansen; Nawar Hanna; Firas Abdollah; Shahrokh F Shariat; Alberto Briganti; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2011-12-03       Impact factor: 20.096

Review 7.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

8.  Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

Authors:  William C Huang; Elena B Elkin; Andrew S Levey; Thomas L Jang; Paul Russo
Journal:  J Urol       Date:  2008-11-13       Impact factor: 7.450

9.  Radical versus partial nephrectomy: effect on overall and noncancer mortality.

Authors:  Laurent Zini; Paul Perrotte; Umberto Capitanio; Claudio Jeldres; Shahrokh F Shariat; Elie Antebi; Fred Saad; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

10.  Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study.

Authors:  Yejin Mok; Kunihiro Matsushita; Yingying Sang; Shoshana H Ballew; Morgan Grams; Sang Yop Shin; Sun Ha Jee; Josef Coresh
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.